Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by NeOnc Technologies Holdings, Inc.

< Previous 1 2 Next >
News headline image
NeOnc Technologies Granted FDA Type B End-of-Phase Meeting to Discuss Potential Accelerated Approval Pathway and Phase 3 Confirmatory Trial for Intranasal NEO100
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc CEO Amir Heshmatpour Adds 80,000 Shares in Open-Market Purchases
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies and the Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical Collaboration
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc CEO Amir F. Heshmatpour to Address Global Life Sciences Investment at Abu Dhabi Future Health Summit 2026
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Provides Business Update and Reports Q1 2026 Financial Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies Reports Updated Clinical Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
News headline image
NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.